8-K filing — Tevogen Bio Holdings Inc. (TVGNW)
Filed: 2026-07-30 AccNo: 0001493152-26-035334 Size: 440 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits
Stocks · News reference
8-K filing — Tevogen Inc. (TVGNW)
Filed: 2026-09-16 AccNo: 0001493152-26-042952 Size: 377 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Tevogen Bio Announces 2026 Annual Meeting of Stockholders
Tevogen Bio Holdings Inc. (NASDAQ: TVGN) announced its 2026 Annual Meeting of Stockholders scheduled for August 24, 2026, to be held virtually. The company has set July 23, 2026 as the record date for stockholders and the deadline for submitting stockholder proposals and director nominations. Tevogen continues to focus on its three complementary initiatives: Tevogen Bio (biotechnology), Tevogen.AI (artificial intelligence and technology), and Tevogen Healthcare Services, aimed at improving affordability and accessibility of life-saving medicines.